Sitemap
Pages
- Signatures
- Therapeutic area – Bronchiectasis Disease
- Therapeutic area – Severe Asthma
- Therapeutic area – Cystic Fibrosis
- Coordinated Vulnerability Disclosure Policy
- Request an appointment
- Webinar Access
- Search
- Lung Interventions
- Therapeutic area – COPD
- Privacy Policy
- Evidence & Expertise – Insights
- Drug Development
- Technology
- Sitemap
- Quality & Compliance
- Blog
- News
- Contacts
- About us
- Homepage
Posts
- Beyond the Algorithm – Driving Clinical Impact Through Compliance
- Redefining Bronchiectasis Trials Through AI-Powered Image Analysis
- Thirona Receives FDA Clearance for LungQ® 4 Software, Expanding AI-Powered Capabilities in Lung Image Analysis for the U.S. Market
- Thirona and VIDA Diagnostics Partner to Accelerate Respiratory Clinical Trials with Advanced AI Imaging
- Renewed ISO 13485 and MDR Approvals, and our 1st MDSAP Certification
- Welcoming internationally renowned pulmonologists to Thirona’s Medical Advisory Board
- Thirona and COPD Foundation Partner to Advance AI-Driven Phenotyping of COPD Patients
- Optimizing Imaging Outcomes: Why Lung Volume Control Can Make or Break the Success of a Respiratory Clinical Trial
- Artificial Intelligence detects substantial airway damage on CT scans of children with severe asthma
- Thirona Spinout Thirona Retina BV Acquired by Revenio Group
- Welcoming top clinical experts to Thirona’s Medical Advisory Board
- Blackford and Thirona Partner to Enhance Lung Image Analysis
- Autonomous AI Revolutionizes Cancer Detection
- Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases.
- Comprehensive assessment of mucus impaction with Artificial Intelligence
- 10 years of innovating AI in lung imaging – What a journey!
- LungQ 3.0.0 receives FDA 510(k) clearance
- Aidence, Incepto, and Thirona launch joint clinical solution to support the expansion of lung cancer screening in Europe
- Automatic airway analysis with artificial intelligence
- Thirona Raises €7,5 Million New Financing
- Pulmonary hypertension: ongoing research
- Thirona awarded to receive EIC grant
- Artificial Intelligence Could Enable Life-Saving Early Diagnosis and Advance the Treatment of Pulmonary Hypertension
- Phenotyping vascular lung disease patients: new ways with imaging-based markers
- AI in phenotyping of pulmonary blood vessels: Redefining diagnosis and treatment of pulmonary vascular diseases.
- 4 Critical Steps to Effective Clinical Trials with Lung Imaging
- Thirona spins out the Retina business to pursue long-term growth plans
- Bringing AI into hospitals – Empowering personalized patient treatment
- NLAIC Matchmaking for AI Startups in Healthcare
- From Scientist to CEO: My journey to pioneer AI in Precision Medicine
- Predictive powers of Thirona’s CAD4COVID in COVID-19 patients
- ISO 27001 certification for Thirona assures that patients’ data is handled according to stringent information security guidelines
- Amazon Web Services supports Thirona’s innovation in diagnostic research
- ATS 2022, San Fransisco: AI in medical imaging is taking off
- Thirona partners with Free Flow Medical for AI-powered clinical solutions to treat COPD patients
- Thirona and Pulmonx have extended their strategic partnership, which leverages Thirona’s AI-powered solutions in Pulmonx StratX® platform
- Thirona appoints Chief Medical Officer
- Thirona closes financing round with HERAN Partners and Borski Fund
- Thirona is present at ATS and Radiology days
- Thirona’s artery-vein and segment segmentation helps in lung cancer surgeries
- Thirona launches AI software for Cystic Fibrosis
- LUMC calculates lung damages COVID-19 patients with AI technology
- Update from Thirona
- The Canisius Wilhelmina Ziekenhuis in Nijmegen is now using CAD4COVID-CT in their clinical practice!
- Thirona is now compliant with the new Medical Device Regulation
- Thirona obtains patent for quantitative analysis of Cystic Fibrosis in children
- Thirona partners with P4O2 consortium to study long-term effects of COVID-19
- Thirona’s CT analysis helps VR-visualization of lungs for pre-operative planning
- Thirona Teams Up with Smart Reporting to Further Improve Covid-19 Detection
- Thirona is present at the ECR
- CAD4COVID-XRay performs comparable to radiologists
- CAD4COVID in Top 10 innovations at UNECA Innovation Challenge
- RetCAD is cleared for clinical use in New Zealand
- CAD4COVID-XRay and CAD4COVID-CT are CE certified
- LungQ is cleared for clinical use in South Korea
- We have launched CAD4COVID-CT
- Triage for COVID-19 Using AI on Chest X-rays
- Happy birthday to us!
- EFRO subsidy to Thirona, RadboudUMC en Quirem
- Our LungQ software picks up progression in emphysema and air trapping
- RetCAD validation and approval
- Thirona starts a collaboration with UKE
- Thirona in de Gelderlander
- Thirona is present at the ERS
- Opening of Thira Lab
- Thirona is present at the ESCRS conference
- Thirona is at the ATS conference
- CAD4TB v6 evaluation paper